In the field of structure-activity relationship (SAR) studies, the software programs CASE (computer-automated structure evaluation) and MULTICASE, created by Klopman and Rosenkranz (1) , represent an original approach for elucidating mechanisms of interaction between biological systems and exogenous compounds to predict the biological activities of chemicals. The strategy adopted is based on the hypothesis that molecular connectivity identifies the tridimensional structure: fragments of connected atoms and their interatomic bonds determine to a significant extent angles between pairs of contiguous atoms and their interatomic distance. The program should be able to detect, with the help of a statistical procedure, the submolecular structures that could interact with biological sites (i.e., receptors) involved in the biological process analyzed. The structure can be responsible for the biological activity of the compound (biophore) or its inhibition (biophobe). This view partially agrees with the work of Ashby and Paton (2) , who singled out specific molecular fragments associated with genotoxicity.
The analytical capabilities of CASE increase with the amount of data input. CASE minimizes the possibility of bias due to human factors because it identifies parameters objectively, independent of human judgment. The only human operations are the choice of the data to be submitted to analysis and the interpretation of data in output. The selection of the descriptors (molecular fragments) that are used to predict biological activity is completely automated. The choice of descriptors is based on statistically significant prevalence in active or inactive molecules.
Since 1984, many studies have been published by Klopman and Rosenkranz (3) (4) (5) (6) (7) (8) (9) (10) (11) on this subject: sets of congeneric and noncongeneric compounds have been tested for several biological endpoints (mutagenicity, carcinogenicity, etc.). We have selected for discussion in this report some papers among the most pertinent to our work. Concerning predictivity, the results obtained by Klopman and Rosenkranz change for different endpoints and for different chemical classes analyzed and overall show a high level of accuracy; often, however, predictivity has been tested only in the training set or in arbitrarily built test sets.
The general strategy of CASE is known, but the detailed structure of the software is not available because it is protected by copyright. Up to now, all reports on predictivity using CASE have been published solely by the program creators or by authors using the CASE program by license or permission. Due to these restrictions, we saw the need to develop a new, completely independent program to confirm (or disprove) the validity of the type of SAR approach used by CASE.
Our software uses graph theory to reproduce basic operations characterizing the CASE program. The program associates a graph with a molecule to represent its topological properties. The program searches for subgraphs (molecular fragments) characteristic of groups of carcinogenic or noncarcinogenic compounds. To test the performance of the software, we chose the induction of tumors in rodents as a biological endpoint. Tumors are the endpoint of carcinogenesis, a complex multistage event, in which genetic alterations are only one part of the story. We used the Carcinogenic Potency Database (CPDB) (12) (13) (14) (15) and the National Toxicology Program (NTP) (16) (17) (18) data to obtain information on rodent carcinogenicity. We divided the data into two subsets: a randomly selected learning set including 80% of the chemicals, and a nonoverlapping test set including 20% of the chemicals. An additional control analysis tested an artificially paired set of data where carcinogenicity is attributed randomly to the molecules of the training set but not to the molecules of the test set.
Methods Software Features
To analyze the possible relationships between the structure of molecular fragments and carcinogenicity, our software analyzes the topological properties of molecular fragments using graph theory. For a detailed introduction to graph theory, see Christofides (159) .
Graph theory is used to relate the topological properties of molecules to their possible carcinogenicity. A graph is a pair (V, E), where Vis the set {vi, i= 1,...n} of vertices, and E is the set {eij = (vi, v), vi, v; E 1/ of edges that express existing relations between vertices; both vertices and edges may be labeled (i.e., they may have an associated name or value). Any compound can be represented as a graph by associating the atoms with the vertices and the bonds with the edges. This kind of representation is frequently adopted in literature because it allows easy handling of the topological properties of compounds. In fact, graph theory has many applications, such as in nomenclature, coding and information processing, storage, and retrieval (20) .
Our software system uses a fragmentation approach to determine whether subfamilies of compounds with carcinogenic activity, or lack thereof, are characterized by the presence of some common structural features (molecular fragments). A similar approach has already been applied in earlier computer-aided methods (21) (22) (23) for predicting different biological activities (antiarthritic-immunoregulatory effects and antineoplastic effects). In these earlier works, not all the possible fragments within a given range of nonhydrogen atoms were generated, but only a limited subset of fragments, such as augmented atoms, heteropaths, and ring fragments. A definition of these substructural units is given by Chu et al. (22) . Our work is mainly based on the works of Rosenkranz and Klopman (3, 4) and on the studies of Ashby (24, 25) , who has defined indicators that can be thought of as subgraphs usually present in genotoxic compounds (genotoxicity is an important component of carcinogenicity).
Essentially, the system searches all the fragments (i.e., subgraphs) of the compounds present in the training set whose activity is known, in an attempt to determine a reliable set of fragments whose presence in compounds of unknown carcinogenicity (test set) may be an indicator of their activity. In particular, the main procedure of the program that executes the fragmentation works as follows: all the fragments within a given size of each compound of the training set are produced; a unique code is associated with any fragment yielded, and, if this code is not already present in a fragment dictionary, it is inserted in the dictionary. A list of the compounds to which the fragment belongs is linked to the fragment code and it is initially filled with the code of the compound currently examined. Otherwise, if the fragment code is already present in the dictionary, only the corresponding compound list is updated. Once all the compounds of the training set have been fragmented, the system scans the dictionary by searching for the fragments that satisfy the statistical conditions (described in later).
The program was developed in standard C language, and it can be compiled on both MS-DOS 
where Nis the number of times in which a given fragment has been generated in different molecules (trials); X is the number of times in which the fragment has been generated by positive molecules (successes); p is the probability that one fragment has been generated by a positive molecule (probability of success); its value is determined by the ratio p fragments generated by positive chemicals (_ 159,000) fragments generated by all chemicals (_ 278,000) q is the probability that the fragment has been generated by a nonpositive molecule (probability of failure = 1 -p); and Pr(X) is the probability of X successes (single monomial).
The fragments selected in this way are labeled "activating" if their occurrence in carcinogenic chemicals is higher than the statistical limit that we established. Similarly, the fragments are labeled "inactivating" if their occurrence in nonpositive compounds is higher than the established statistical limit. In a second stage, the program removes the fragments that are redundant because they are "imbedded" in larger fragments and 
X~~~~~Prbblt Index carcinogenic properties and all the molecules contributing to the evaluation is 0.6. This value is used as a PI.
A successive step is the calculation of the PI value that is used as a cut-off value to define two categories (positives and negatives) of predicted activity for the test set. This cut-off index is the value that maximizes the accuracy of the contingency table 2 x 2 (carcinogenicity or lack thereof versus predicted activity) in the training set.
Accuracy in the training set as a function of the PI is illustrated in Figure 1 . Levels of accuracy higher than 0.73 are obtained in the training set in a range of PI values between 0.35 and 0.8. This is because the majority of molecules have a probability index higher than 0.8 or lower than 0.35 (Fig. 2) . A cut-off within this range only slightly affects the attribution to the carcinogenic or noncarcinogenic class. The average optimal cut-off value for eight runs was 0.41.
Preliminary runs of our program showed, for partial subsets of carcinogenicity data, statistical fluctuations in terms of predictivity indices. For this reason, we performed eight runs using our final database (826 compounds, 515 carcinogens and 311 noncarcinogens). For each run we randomly drew 80% of compounds for the training set and used the remaining 20% as the test set. We also performed eight paired runs using the same chemicals, but, in this case, the property of carcinogenicity in the training set was randomly attributed (pseudo-training set). The procedure for randomly selecting the chemicals for the training set and the test set imposed the condition that in both sets, 62.3% of the chemicals must be positive carcinogens. This simple procedure uses a routine of BASIC language (RANDOMIZE TIMER) as a random-number generator to assign the chemicals for the training sets and to assign the carcinogenic property in the pseudo-training sets.
To evaluate the predictivity level of our methodology, we adopted some indices that are conventionally used for diagnostic tests: In addition, according to Klopman and Kolossvary (26), we evaluated the following two parameters:
where Xis the fraction of active molecules in the data set, and Y is the fraction of molecules predicted as active. The 315 fragments obtained from the training stage are prevalently "inactivating" (60.6%), and only 39.4% are "activating." This fact may be due to the ratio between fragments generated from carcinogens and noncarcinogens in the database studied. In our global database we have more carcinogens (62.3%) than noncarcinogens (37.7%). However, noncarcinogens have an average size larger than carcinogens (15.1 heavy atoms versus 13.0 heavy atoms). Most likely for this reason, out of the total number of generated fragments (redundant fragments included), 57.0% come from carcinogens and 43.% from noncarcinogens. Figure 3 shows the distribution of the occurrences of 103,000 fragments of the average training set. In the case of negative fragments, those present in three noncarcinogens reach our established limit of statistical significance (0.433<0.125). This is not the case for positive fragments (0.573>0.125). For a positive fragment to become significant, it has to be wresent in at least four carcinogens (0.57 <0.125). As shown in Figure 3 , many more fragments are present at least three times than those present at least four times. Statistically significant negative fragments can be sorted from a larger set than statistically significant positive ones.
As a consequence, even if we start with Carcinogenicity randomly attributed; average of eight runs (± SE).
aAs defined in Klopman and Kolossvary (26) . 'As defined in Klopman and Kolossvary (26) . seem to show a high level of predictivity. However, even the indices obtained with the eight training sets where carcinogenicity was randomly attributed (Table 6) show a high predictivity performance. It is clear that the results obtained are not due to the predictive capability of the program but mainly to the many degrees of freedom existing in the system. These degrees of freedom allow for an a posteriori adaptation of the program to the pattern of positive and negative data in the training sets. In conclusion, the training sets cannot be used for an assessment of predictivity. It must be noted that the pseudo-training sets generate less "significant" fragments than the real training sets. As a consequence, there are fewer chemicals associated with a positive or negative prediction (376.9) in respect to the real training sets (521.6). 
Discussion
The major drawback to this type of automated analysis is the number of elementary operations performed and the quantity of memory needed. Determining the largest common subgraph between two graphs is a nonpolynomial task and requires time that exponentially depends on the size of the graphs and subgraphs involved. Fortunately, some characteristics of the chemical compounds partially simplify this otherwise formidable task: 1) the maximum number of edges converging at a node is usually small (around four); 2) the number of atoms in the compounds of our database is relatively small: the average number of heavy atoms (nonhydrogen) per compound is 13.8, and the largest compound contains 48 heavy atoms (see Fig. 4) ; 3) the maximum size of the searched fragments was limited to eight heavy atoms. As can be observed in Figures 5 and 6 , fragments of greater size tend to appear in large numbers, but each of them tend to be present in too few compounds to be statistically significant. We have also observed that in our database, the information (associated with carcinogenicity or lack thereof) related to fragments of size 9 is redundant in respect to the information of smaller sizes in 100% of the cases (data not reported).
Finally, thus far, the adopted technique of representation of molecular fragments does not make a distinction among steric isomers; such cases will be dealt with in a future improvement to the system. We have described the method for calculating our PI value in Methods. We used the PI value as a discriminant for deciding if a molecule of the test set will be predicted to be a carcinogen or a noncarcinogen. The strategy adopted prevents As a general result, we have confirmed what has been suggested by Klopman and Rosenkranz (4) : an approach based on molecular connectivity can predict carcinogenicity. The results obtained in our test sets are statistically significant (p-0.0006). We believe that the observed levels of predictivity are not only statistically significant but also biologically relevant and potentially useful as one component of a spectrum of information that can contribute to hazard evaluations. Our initial work is promising, but we must test the software in additional experiments to develop it as a predictive toxicology system. For instance, we have to investigate in detail the performance of our program for different thresholds of statistical significance when we are selecting significant fragments from the training set to be used for predictions in the test set.
We can logically presume that with a smaller (and/or less diversified) training set, a fragment potentially associated with carcinogenicity or lack thereof could not reach statistical significance (or reach a more equivocal statistical significance). Therefore, we would expect that the percentage of nonassessable chemicals should decrease for a larger training set, and we should obtain better predictivity in general.
We plan to test our software program using smaller training sets (i.e., from 200 to 400 chemicals randomly selected) to verify if our assumption is correct. Klopman and Rosenkranz (11) have already verified this assumption. However, for the moment, we do not know if the similarities between the CASE program and our program are sufficient to allow extrapolation of their results to the results of our program.
We also have to look in detail at the fragments selected as significant to comment about their biological plausibility and compare them with the alert structures of Ashby (2, 16, 17, 18, 24, 25) and also with fragments identified by the CASE and MULTICASE programs. We plan to coordinate with the authors of CASE and MULTICASE to test our respective programs with identical training sets and identical test sets so that we can compare the results obtained.
We used a database much larger than those used previously by other authors. We have obtained an average (eight runs) level of accuracy of 67.5% (SE, ±1.3). As shown in Table 7 , we predicted 82.1 chemicals as positive and 44.4 as negatives. If these predictions (with the same proportions of predicted positives and negatives) had been based only on chance, the level of accuracy would have been 53.2% (ECP value). In our database, the prevalence of positive carcinogens is 62.3%. If we had predicted all the chemicals of the test sets as carcinogens, we would have obtained an accuracy of 62.3%. When you predict that all chemicals are potential carcinogens, the sensitivity is 100% and the specificity is 0%, and the prediction is not very useful.
An accuracy of 62.3% is apparently not very different from 67.5%, but we would anticipate for our software program levels of accuracy in the range of 65-70% at a ratio of carcinogens/noncarcinogens of 50/50, or even 38/62. We plan to perform these experiments in a future study.
Different levels of predictivity were observed for different subclasses of chemicals. For instance, the confidence of the prediction for a chemical of the test sets, characterized only by positive fragments, is significantly higher (78.7%) than the confidence of the prediction for a chemical characterized only by negative fragments or contradictory fragments (60.7% and 59.3%, respectively).
We have met some difficulties in performing a direct comparison of our results with the results obtained by CASE. At the level of the training set, accuracy was higher (95%) for CASE (8,9) than for our program. This difference is probably related to differences in the decisional-statistical procedures used for the information obtained from different molecular fragments. In addition, the carcinogenicity database used by Klopman and Rosenkranz was different from ours. We have clearly demonstrated that accuracy at the level of the training sets is not correlated to the real predictivity of the software program (compare Tables 6 and 8) .
A test set concerning carcinogenicity is present in two different reports by Klopman and Rosenkranz (8, 9) . The training set contained 189 chemicals of the NTP study (50.2% active, 22.2% marginally active, and 27.5% noncarcinogens). The rodent carcinogens (or noncarcinogens) considered in the test sets of the two papers are the same chemicals. They had been evaluated for carcinogenicity in the GeneTox program. In this test set, 23 out of 24 chemicals were rodent carcinogens. The expected correct predictivity was 92%, and the observed predictivity (accuracy) was 100%. Obviously, it is not possible to directly compare this extremely unbalanced database with ours.
In 1990, an analysis of the capability of CASE to predict carcinogenicity for a group of polycyclic aromatic hydrocarbons was reported by Richard and Woo (27) . Thirty-one active and 25 inactive PAHs were used in the training set ("LEARN"), and 9 active and 15 inactive PAHs were used in the test set ("VALIDATE"). The authors reported an accuracy of 75% (SE, 89%; SP, 67%). In a recent publication (28) (29) , mainly electrophiles (directly or after metabolic activation) are involved in Salmonella mutagenicity. It is reasonable to think that mutagenicity in Salmonella should be more easy to predict than the complex endpoint of carcinogenicity: phenomena such as promotion, clonal expansion, remodeling, tissue necrosis and regeneration, and modulation of proliferation, apoptosis, and differentiation are clearly involved in the carcinogenic process, but not in mutagenicity in Salmonella or in other short-term tests of genotoxicity. We would expect a wider and more heterogeneous spectrum of molecular fragments to be involved in carcinogenicity than in genotoxicity. In the future, we will have to apply our software program not only to carcinogenicity but also to mutagenicity in Salmonella to test our hypothesis that it is in general easier to predict genotoxicity than carcinogenicity.
After analyzing recent studies evaluating the qualitative correlation between short-term tests for genotoxicity and carcinogenicity (30, 31) , we conclude that accuracy is in the range of 56-62%. It seems reasonable that short-term genotoxicity tests can reflect irreversible alterations in the genome during carcinogenesis. On the other hand, short-term tests should not be able to monitor nongenotoxic events (for instance, those events linked to pro-____-e motion and clonal expansion of preneoplastic cells). The fact that the predictivity of molecular connectivity is better than the predictivity of short-term genotoxicity tests suggests that molecular connectivity can detect not only electrophilic fragments, like the ones described by Ashby et al. (2, (16) (17) (18) 24, 25) , but also fragments linked to nongenotoxic effects (promotion, modulation of differentiation, etc.). An alternative explanation of this difference in accuracy could be related to the fact that nongenotoxic carcinogens may be more abundant in the databases used to assess the predictivity of short-term tests (30, 31) than in our larger database. In the future we will investigate the predictivity of molecular connectivity for genotoxic and nongenotoxic carcinogens.
We have discussed the predictive capability of short-term genotoxicity tests. We agree with this observation. Because we found in the pseudo-training sets a number of apparently significant fragments equal to about 55% of the statistically significant fragments found in the real training sets, we suspect that (as a first approximation) about half of the fragments defined as significant according to our statistical threshold (p<O. 125, one tailed) are spurious. According to our analysis, only about 50% of apparently significant fragments emerging from a training set can be fragments of real biological significance. The remaining 50% is probably generated by chance and can also be present in a pseudo-training set in which carcinogenicity is assigned randomly. The level of predictivity reached in our experiments is probably due to a mixture of approximately 50% predictive fragments and approximately 50% of noise fragments. We think that fragments suggested as significant by our software program should be considered only as candidates for biological significance, but are by no means foolproof biological indicators of carcinogenicity. Their probability of being significant is higher, as expected, when we select a more severe statistical threshold. As a consequence of these considerations, a new potentially significant fragment detected by our software program is only submitted to the attention of investigators as a possible fragment characterizing a subfamily of molecules, potentially responsible for their common carcinogenic activity. Additional biological and chemical considerations could lead to the acceptance or rejection of the fragment as biologically significant. For instance, if the chemicals considered are similar procarcinogens, a similar metabolism should generate similar proximate carcinogens and perhaps also similar DNA adducts.
There are also cases in which it is impossible to reach a definite conclusion. Statistical significance is only one factor; however, when the statistical threshold is much more severe (p<0.01 instead of p<0. 125), the number of significant fragments generated in a real training set is four to five times larger than the number of significant fragments generated in a pseudo-training set (against a ratio of 2/1 for the threshold, p<0.125). Fragments with a higher statistical significance deserve priority in subsequent biological investigations with the aim of confirming or disproving the existence of a new molecular structure relevant for carcinogenicity or genotoxicity. On the other hand, the information obtained with the threshold p<0.125, while less significant than the information obtained with the threshold p<0.01, still allowed us to make predictions about a much larger fraction of chemicals. For this reason, the threshold p<0.125 was selected for the general predictivity study presented here.
We have used the overall evidence of carcinogenicity in at least one species, one sex, and one tissue, without any consideration about carcinogenic potency to determine whether or not a chemical is a carcinogen (yes or no). In the future we plan to stratify our database according to spectrum of carcinogenicity (large spectrum, narrow spectrum), as suggested by Tennant institution at the end of the exchangeship.
